S&P Futures
3,926.75 +27.25 (+0.70%) Dow Futures
31,388.00 +175.00 (+0.56%) Nasdaq Futures
11,931.25 +90.50 (+0.76%) Russell 2000 Futures
1,785.00 +12.80 (+0.72%) Crude Oil
109.83 -0.45 (-0.41%) Gold
1,846.70 +4.60 (+0.25%)
Smith & Nephew plc (SNN)
After hours:
Chart Events
Performance Outlook
| Previous Close | 31.55 |
| Open | 31.94 |
| Bid | 28.25 x 800 |
| Ask | 39.01 x 800 |
| Day's Range | 31.49 - 32.01 |
| 52 Week Range | 29.40 - 44.47 |
| Volume | |
| Avg. Volume | 938,590 |
| Market Cap | 13.949B |
| Beta (5Y Monthly) | 0.38 |
| PE Ratio (TTM) | 26.78 |
| EPS (TTM) | 1.19 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.75 (2.35%) |
| Ex-Dividend Date | Mar 31, 2022 |
| 1y Target Est | 38.47 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SNN
Related Research
- Smith & Nephew SNATS, Inc.Analyst Report: Smith & Nephew plcSmith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.RatingFair ValueEconomic Moat23 days agoMorningstar
- Simply Wall St.
Smith & Nephew (LON:SN.) stock falls 5.1% in past week as three-year earnings and shareholder returns continue downward trend
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
- The Telegraph
Questor: Smith & Nephew may look expensive at a p/e of 29 but the figure is deceptive
The absence of any nasty surprises, after a couple of disappointing updates in 2021, represents a good start to 2022 for Smith & Nephew and this column continues to believe that the orthopaedics, wound care and sports medicine specialist could yet be a beneficiary of anything like a return to normality in hospitals as and when the pandemic finally wanes.
- Insider Monkey
11 Best UK Stocks to Buy Now
In this article, we discuss 11 best UK stocks to buy now. If you want to see some more stocks from our selection, click 5 Best UK Stocks to Buy Now. Market experts and analysts from advisory firms believe that the underlying economic recovery after the pandemic has been erased almost completely in the current […]
